| 作者 | 治疗方式 | n | A/B/C (n/n/n) | 男/女 (n/n) | 中位年龄 (岁) | 平均随访时间 (月) | Cochrane 评分 |
| K.K.C.Ng, 等 [6] | RFA | 109 | 104/5/0 | 86/23 | 57 (23~78) | 93个月 | 5 |
| HR | 109 | 107/2/0 | 89/20 | 55 (31~82) | 93个月 | ||
| Hae Won Lee, 等 [7] | RFA | 34 | 34/0/0 | 24/10 | 56.1 ± 7.4 | 64.93个月 (1~93.57个月) | 4 |
| HR | 29 | 29/0/0 | 23/6 | 55.6 ± 7.9 | 64.93个月 (1~93.57个月) | ||
| Yong Fang, 等 [8] | RFA | 60 | 32/23/5 | 42/18 | 51.4 ± 8.1 | 40个月 | 4 |
| HR | 60 | 43/17/0 | 46/14 | 53.5 ± 11.0 | 40个月 | ||
| Wei-Xing Guo, 等 [9] | RFA | 94 | 63/31/0 | 78/16 | 56 (19.0~75.0) | 28个月 (7~75个月) | 3 |
| HR | 102 | 95/7/0 | 94/8 | 51.5 (18.0~75.0) | 32个月 (6~86个月) |